Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8GV6

Crystal structure of PN-SIA28 in complex with influenza hemagglutinin H14 (A/long-tailed duck/Wisconsin/10OS3912/2010)

8GV6 の概要
エントリーDOI10.2210/pdb8gv6/pdb
分子名称Hemagglutinin H14-HA1, Hemagglutinin H14-HA2, PN-SIA28 heavy chain, ... (6 entities in total)
機能のキーワードinfluenza, hemagglutinin, antibody, broadly neutralizing, viral protein, viral protein-immune system complex, viral protein/immune system
由来する生物種Influenza A virus (A/long-tailed duck/Wisconsin/10OS3912/2010(H14N6))
詳細
タンパク質・核酸の鎖数10
化学式量合計221537.30
構造登録者
Chen, Y.,Song, H.,Qi, J.,Gao, G.F. (登録日: 2022-09-14, 公開日: 2022-12-21, 最終更新日: 2024-11-13)
主引用文献Chen, Y.,Wang, F.,Yin, L.,Jiang, H.,Lu, X.,Bi, Y.,Zhang, W.,Shi, Y.,Burioni, R.,Tong, Z.,Song, H.,Qi, J.,Gao, G.F.
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes.
Nat Commun, 13:7603-7603, 2022
Cited by
PubMed Abstract: Influenza infection continues are a persistent threat to public health. The identification and characterization of human broadly neutralizing antibodies can facilitate the development of antibody drugs and the design of universal influenza vaccines. Here, we present structural information for the human antibody PN-SIA28's heterosubtypic binding of hemagglutinin (HA) from circulating and emerging potential influenza A viruses (IAVs). Aside from group 1 and 2 conventional IAV HAs, PN-SIA28 also inhibits membrane fusion mediated by bat-origin H17 and H18 HAs. Crystallographic analyses of Fab alone or in complex with H1, H14, and H18 HA proteins reveal that PN-SIA28 binds to a highly conserved epitope in the fusion domain of different HAs, with the same CDRHs but different CDRLs for different HAs tested, distinguishing it from other structurally characterized anti-stem antibodies. The binding characteristics of PN-SIA28 provides information to support the design of increasingly potent engineered antibodies, antiviral drugs, and/or universal influenza vaccines.
PubMed: 36494358
DOI: 10.1038/s41467-022-35236-y
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.4 Å)
構造検証レポート
Validation report summary of 8gv6
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon